Proposed $480M OPKO/Prolor Merger Has Law Firms Circling
By Jennifer Boggs
Thursday, April 25, 2013
Within hours of Wednesday's announcement that OPKO Health Inc. and Israeli firm Prolor Biotech Inc. are seeking to merge in an all-stock transaction valued at about $480 million, several law firms said they were launching investigations into the deal on behalf of shareholders.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.